Year archive

3D Medicines Inc. — 2025 filings

All 37 regulatory filings released by 3D Medicines Inc. (1244) in 2025, sourced directly from the official regulator.

37 Filings

2025 Period

2025 filings (37)

Filing	Released	Lang
VOLUNTARY ANNOUNCEMENT ENVAFOLIMAB GRANTED ORPHAN-DRUG DESIGNATION FOR TREATMENT OF GASTRIC CANCER AND GASTRO-ESOPHAGEAL JUNCTION CANCER INDICATIONS Regulatory Filings	2025-12-22	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025 Regulatory Filings	2025-12-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025 Regulatory Filings	2025-11-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025 Share Issue/Capital Change	2025-10-06	English
Interim Report 2025 Interim / Quarterly Report H1 2025	2025-09-30	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025 Regulatory Filings	2025-09-04	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025 Interim / Quarterly Report H1 2025	2025-08-29	English
VOLUNTARY ANNOUNCEMENT SUCCESSFULLY ADMINISTERS FIRST DOSE IN HUMAN FOR NOVEL RADIOACTIVE DRUG CONJUGATE 3D1015 Regulatory Filings	2025-08-28	English
VOLUNTARY ANNOUNCEMENT 3D MEDICINES AND CATUG BIOTECHNOLOGY JOIN FORCES TO ADVANCE TLNP-DELIVERED IN VIVO CAR-T/NK THERAPY DEVELOPMENT Regulatory Filings	2025-08-20	English
DATE OF BOARD MEETING Report Publication Announcement	2025-08-19	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025 Share Issue/Capital Change	2025-08-06	English
INSIDE INFORMATION WITHDRAWAL OF CIVIL PROCEEDINGS BY QINGDAO HAINUO Legal Proceedings Report	2025-07-22	English
SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE STRATEGIC COOPERATION AGREEMENT AND UPDATES ON CIVIL PROCEEDINGS Legal Proceedings Report	2025-07-14	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2025 Regulatory Filings	2025-07-04	English
DISCLOSEABLE TRANSACTION CONNECTED TRANSACTION AT SUBSIDIARY LEVEL IN RESPECT OF THE STRATEGIC COOPERATION AGREEMENT Regulatory Filings	2025-07-02	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2025-06-30	English
(1) POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 30, 2025; (2) APPOINTMENT OF NON-EXECUTIVE DIRECTOR; AND (3) CHANGE OF COMPOSITION OF THE AUDIT COMMITTEE Declaration of Voting Results & Voting Rights Announcements	2025-06-30	English
Form of proxy for the Annual General Meeting to be held on Monday, June 30, 2025 Proxy Solicitation & Information Statement	2025-06-05	English
NOTICE OF ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2025-06-05	English
GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; RE-ELECTION OF RETIRING DIRECTORS; PROPOSED APPOINTMENT OF NON-EXECUTIVE DIRECTOR; RE-APPOINTMENT OF AUDITOR; AND NOTICE OF Proxy Solicitation & Information Statement	2025-06-05	English
CHANGE OF NON-EXECUTIVE DIRECTOR AND CHANGE OF COMPOSITION OF THE AUDIT COMMITTEE Board/Management Information	2025-06-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025 Share Issue/Capital Change	2025-06-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025 Regulatory Filings	2025-05-07	English
Annual Report 2024 Annual Report FY 2024	2025-04-30	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025 Regulatory Filings	2025-04-03	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024; AND CHANGE OF COMPOSITION OF THE NOMINATION COMMITTEE Earnings Release FY 2024	2025-03-31	English
Terms of Reference for the Nomination Committee Governance Information	2025-03-31	English
List of Directors and their Roles and Functions Governance Information	2025-03-31	English
Next Day Disclosure Return Transaction in Own Shares	2025-03-25	English
DATE OF BOARD MEETING Regulatory Filings	2025-03-19	English
VOLUNTARY ANNOUNCEMENT SIGNIFICANT BREAKTHROUGH ACHIEVED IN THE DEPLOYMENT OF "AI + mRNA" CANCER VACCINE STRATEGY Regulatory Filings	2025-03-11	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025 Regulatory Filings	2025-03-06	English
UPDATE ON CIVIL PROCEEDINGS Legal Proceedings Report	2025-02-17	English
VOLUNTARY ANNOUNCEMENT APPOINTMENT OF CHIEF COMMERCIAL OFFICER Board/Management Information	2025-02-10	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025 Share Issue/Capital Change	2025-02-03	English
INSIDE INFORMATION IN RELATION TO CIVIL PROCEEDINGS Legal Proceedings Report	2025-01-24	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024 Share Issue/Capital Change	2025-01-02	English